Tags:Science & Tech
For Prelims: Artificial Intelligence (AI), Machine Learning (ML), Molecular Docking, Convolutional Neural Network (CNN)
For Mains: In silico drug discovery, Computational biology, AI in healthcare
Source:
Hindustan
5 facts for one-day exams
SSC, railway, police and teaching exams ask direct questions like these.
- CDRI scientist said AI can predict molecule-protein interactions for drug discovery.
- Molecular docking analysis is one technique used to study molecule-protein binding.
- Convolutional neural networks analyze 3D molecular structures for drug properties.
- International conference HABIT-2026 was held at MNNIT.
- Amarjeet Yadav from IIT-BHU received the Young Scientist Award.
Why in the news?
AI and machine learning are being leveraged to predict which molecules can target disease-related proteins, potentially slashing the time and cost of drug discovery. The approach uses molecular docking analysis and convolutional neural networks to screen and optimize drug candidates, moving from traditional lab-based testing to computational prediction.
Summary
- AI and ML can predict molecule-protein interactions, reducing the need for extensive laboratory testing of thousands of chemical compounds.
- Two primary techniques are used: molecular docking analysis and convolutional neural networks (CNNs) for 3D molecular structure analysis.
- This computational approach aims to lower both the time and cost of drug discovery, a key goal for pharmaceutical research.
Background
Traditional drug discovery is a lengthy and expensive process, often taking over a decade and costing billions of rupees. It involves screening thousands of chemical compounds in the lab to find a molecule that effectively targets a disease. AI and ML offer a paradigm shift by performing initial screening in silico (on computers), drastically reducing the number of compounds that need physical testing.
Key Analysis and Impact
The two techniques highlighted are molecular docking (analyzing how a molecule fits into a protein's active site) and convolutional neural networks (analyzing 3D molecular structures from multiple angles). These methods can rapidly filter out ineffective molecules and even suggest structural modifications to improve efficacy. This has the potential to accelerate the development of new drugs for diseases like cancer, diabetes, and infectious diseases, and reduce the cost of bringing a drug to market.
Way Forward
The integration of AI into drug discovery is still evolving. Key challenges include the need for high-quality training data, validation of AI predictions in real-world lab settings, and regulatory frameworks for AI-designed drugs. However, initiatives like HABIT-2026, which foster collaboration between institutions (CDRI, MNNIT, IIT-BHU, etc.) and between disciplines (biotechnology, computer science), are crucial for advancing this field in India.
Background GK
Textbook concepts you need to understand this news
- Artificial Intelligence (AI)
- The simulation of human intelligence processes by machines, especially computer systems. These processes include learning, reasoning, and self-correction.
- Machine Learning (ML)
- A subset of AI that enables systems to learn and improve from experience without being explicitly programmed. It uses algorithms to analyze data, identify patterns, and make decisions.
- Molecular Docking
- A computational technique that predicts the preferred orientation of one molecule (a ligand) when bound to another (a protein) to form a stable complex. It is used to predict the strength and nature of the binding.
- Convolutional Neural Network (CNN)
- A class of deep neural networks, most commonly applied to analyze visual imagery. In drug discovery, CNNs can analyze the 3D structure of molecules to predict their properties.
Facts to remember
Tap a card to see the answer. Try to recall it first.
How exams will ask this
- Data: AI/ML can reduce time and cost of drug discovery by predicting molecule-protein interactions.
Common mistake:
Students may confuse the two techniques: molecular docking (binding analysis) vs. CNNs (3D structure analysis). Also, they might swap CDRI with another research institute (e.g., CCMB, IICT).
Write these in mains answers
- In silico drug discovery, Computational biology, AI in healthcare
Stuck? Get it in one tap
AI and machine learning can predict which molecules will work against disease proteins, reducing the need for lab tests. This speeds up drug discovery and cuts costs. For example, instead of testing thousands of chemicals in a lab, a computer can quickly find the best candidates.
- Science and Technology: Artificial Intelligence and Machine Learning
- Science and Technology: Biotechnology and Drug Discovery
Related concepts: Artificial Intelligence (AI), Machine Learning (ML), Molecular Docking, Convolutional Neural Network (CNN)
Practice questions
Pick an answer, then read the explanation.
- Q1Easy
With which institute is the scientist advocating for AI/ML in drug discovery associated?
Explanation: Dr. Mohammad Imran Siddiqui, who spoke about AI/ML accelerating drug discovery, is a scientist at the Central Drug Research Institute (CDRI), Lucknow. IIT-BHU is where awardee Amarjeet Yadav is from. MNNIT hosted the conference. Babasaheb Bhimrao Ambedkar University had a professor who gave a lecture.
- Q2Hard
Consider the following statements regarding AI-enabled drug discovery and HABIT-2026:
- 1.The Central Drug Research Institute (CDRI) is located in Kanpur.
- 2.HABIT-2026 was organized by the Department of Biotechnology.
- 3.The Young Scientist Award was given to Amarjeet Yadav of MNNIT.
Which of the statements given above is/are correct?
Explanation: 1. False: CDRI is located in Lucknow. 2. True: HABIT-2026 was organized by the Department of Biotechnology. 3. False: Amarjeet Yadav is from IIT-BHU.
- Q3Medium
Who received the prestigious Young Scientist Award at the HABIT-2026 conference?
Explanation: Amarjeet Yadav from IIT (BHU) was awarded the prestigious Young Scientist Award at the conference. Dr. Mohammad Imran Siddiqui is a CDRI scientist who gave the talk. Dr. Kirti Doria and Dr. Anshu Rastogi are other participants who presented their views.
- Q4Medium
What is the primary objective of using AI and Machine Learning in drug discovery?
Explanation: The core objective is to use AI/ML to predict which molecules are likely to be effective drugs, thereby reducing the need for extensive and expensive lab testing of thousands of compounds. While it may involve computer simulations, it is not about replacing all lab work. It's about accelerating the initial screening phase.
Frequently asked questions
1. How can AI and machine learning accelerate drug discovery?
AI and ML can predict which molecules will bind to disease-related proteins, reducing the need for extensive laboratory testing of thousands of chemical compounds, thereby saving time and cost.
2. Which institute's scientist made this statement about AI and drug discovery?
The statement was made by Dr. Mohammad Imran Siddiqui, a scientist at the Central Drug Research Institute (CDRI), Lucknow.
3. What is the HABIT-2026 conference?
HABIT-2026 is an international conference organized by the Department of Biotechnology (DBT) at MNNIT, focusing on health, agriculture, food security, and environmental challenges.
4. Who received the Young Scientist Award at HABIT-2026?
Amarjeet Yadav from IIT (BHU) received the prestigious Young Scientist Award for his research at the conference.
All sources
Original1 November 2026 · Read story

